Status:
COMPLETED
Nasal Decongestion and Obstructive Sleep Apnea
Lead Sponsor:
University of Zurich
Conditions:
Obstructive Sleep Apnea Syndrome
Rhinitis
Eligibility:
All Genders
20-75 years
Phase:
PHASE4
Brief Summary
Whether impaired nasal breathing contributes to sleep related breathing disturbances has not been known. Therefore, the purpose of the study is to compare the effect of xylometazoline, a drug that dec...
Eligibility Criteria
Inclusion
- Obstructive sleep apnea syndrome (excessive sleepiness, apnea/hypopnea index \>10/h)
- Chronic nasal congestion (complaint of impaired nasal breathing that interfered with subjective sleep quality on at least 3 nights per week during at least the last 3 months)
Exclusion
- Nasal surgery within the last 6 months
- Current treatment with nasal decongestants or topical steroids
- Sleep disorders other than obstructive sleep apnea
- Internal medical or psychiatric disorders that interfered with sleep
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2005
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00630474
Start Date
January 1 2004
End Date
April 1 2005
Last Update
December 23 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pulmonary Division, University Hospital Zurich, Switzerland
Zurich, Switzerland, CH-8091
2
Pulmonary Division, University Hospital Zurich
Zurich, Switzerland, CH-8091